Key result
Failing DCM hearts show higher cathepsin B expression and greater apoptosis versus non-failing hearts.
Why the study?
The role of myocardial cathepsin B expression in failing versus non-failing human hearts was not well characterized.
Case-Control (n=25)
Increased myocardial expression of cathepsin B in patients with dilated cardiomyopathy correlates with reduced ejection fraction and increased apoptosis, suggesting a role in heart failure progression.
Answers are grounded in this paper and cite their sources.
Cathepsin B may contribute to apoptosis in dilated cardiomyopathy; hypothesis-generating and requires prospective validation before clinical relevance.
OBJECTIVE: Cathepsin B is a prominent lysosomal protease and is involved in apoptosis as well as degradation of myofibrillar proteins in myocardial infarction. The aim of this study was to investigate myocardial cathepsin B expression in failing and non-failing human hearts. METHODS: Tissue samples were taken from transplanted left ventricles from 20 patients with dilated cardiomyopathy and 5 non-failing donor hearts that could not be transplanted for technical reasons. Myocardial cathepsin B expression was determined by immunohistochemistry, the reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. Apoptosis was assessed by TUNEL staining. RESULTS: Positive cathepsin B staining was found in failing and non-failing hearts. The expression of cathepsin B at mRNA and protein levels was significantly higher in failing hearts compared with non-failing hearts. Correlation analysis revealed that cathepsin B at mRNA and protein levels negatively correlated with EF (r=0.66, p=0.002 and r=0.492, p=0.028, respectively) in patients with heart failure. The apoptotic index was 0.015+/-0.006 in failing hearts and 0.002+/-0.001 in non-failing hearts (p<0.01). CONCLUSION: Increased myocardial expression of cathepsin B was found in patients with heart failure suggesting that cathepsin B might play a role in the genesis and development of heart failure.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2006) conducted a case-control in Dilated cardiomyopathy (n=25). Dilated cardiomyopathy vs. Non-failing donor hearts was evaluated on Apoptotic index (p=<0.01). Failing hearts from patients with dilated cardiomyopathy showed higher cathepsin B expression and a higher apoptotic index compared to non-failing hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: